0001687466-25-000004.txt : 20251112 0001687466-25-000004.hdr.sgml : 20251112 20251112100814 ACCESSION NUMBER: 0001687466-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251112 DATE AS OF CHANGE: 20251112 EFFECTIVENESS DATE: 20251112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PIPr Therapeutics, Inc. CENTRAL INDEX KEY: 0001687466 ORGANIZATION NAME: EIN: 813754450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563664 FILM NUMBER: 251470157 BUSINESS ADDRESS: STREET 1: 280 S. MANGUM ST. STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 9193578326 MAIL ADDRESS: STREET 1: 280 S. MANGUM ST. STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27701 FORMER COMPANY: FORMER CONFORMED NAME: Artizan Biosciences, Inc. DATE OF NAME CHANGE: 20161014 D 1 primary_doc.xml X0708 D LIVE 0001687466 PIPr Therapeutics, Inc. 280 S. MANGUM ST. SUITE 350 DURHAM NC NORTH CAROLINA 27701 9193578326 DELAWARE Artizan Biosciences, Inc. Corporation true Heather Madsen 280 S. MANGUM ST. Suite 350 Durham NC NORTH CAROLINA 27701 Executive Officer Director Ms. Madsen is a director and the CEO of the issuer. Clay Thorp 280 S. MANGUM ST. Suite 350 Durham NC NORTH CAROLINA 27701 Director Holden Thorp 280 S. MANGUM ST. Suite 350 Durham NC NORTH CAROLINA 27701 Director Biotechnology Decline to Disclose 06b false 2025-10-31 false true false 0 2499992 1499995 999997 false 3 0 0 0 false PIPr Therapeutics, Inc. Tyler Dove Tyler Dove By POA from Heather Madsen, CEO 2025-11-12